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Abstract: Optimal vitamin D status has commonly been defined as the level of 25-hydroxyvitamin D
(25(OH)D) at which parathyroid hormone (PTH) concentrations would be maximally suppressed,
represented by an observed minimum plateau. Previous findings indicate a large variation in this
plateau, with values ranging from <30 nmol/L up to 100 nmol/L. This disparity in values might
be explained by differences in study design and methodology, ethnicity, age, gender and latitude.
This study aimed to investigate the concentration of 25(OH)D at which PTH concentrations were
suppressed in Brazilian women living in opposite latitudes (high vs. low: i.e., UK and Brazil), during
wintertime. Using data from the D-SOL study (Interaction between Vitamin D Supplementation
and Sunlight Exposure in Women Living in Opposite Latitudes), the association between 25(OH)D
status and PTH levels were examined in 135 Brazilian women (56 living in England and 79 living
in Brazil, aged 20–59 years old). Mean PTH concentrations for Brazilian women with vitamin D
deficiency (<25 nmol/L) were significantly higher compared to those with vitamin D insufficiency
(25–49.9 nmol/L) (p < 0.01), vitamin D adequacy (50–74.9 nmol/L) (p < 0.01) and those with optimal
vitamin D status (>75 nmol/L) (p < 0.001). Regression modelling was used to investigate the
relationship between serum 25(OH)D and PTH for the sample as a whole and for each group
separately. A cubic model was statistically significant for the total sample (p < 0.001), whereas
a linear model presented the best fit for Brazilian women living in England (p = 0.04) and there
were no statistically significant models fitted for Brazilian women living in Brazil. The cubic model
suggests that 25(OH)D concentrations above 70–80 nmol/L are optimal to suppress the parathyroid
gland in Brazilian women. These findings contribute to a better understanding of the relationship
between 25(OH)D and PTH in populations living in a low latitude location and are of great relevance
for discussions regarding the estimation of optimal cut-offs for vitamin D levels in the Brazilian
population as well as for other low latitude locations.
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1. Introduction
The major physiological function of vitamin D and its metabolites is to maintain calcium
homeostasis for metabolic functioning, signal transduction and neuromuscular activity. The biologically
active metabolite 1,25-dihydroxyvitamin D (1α,25(OH)2D3) is involved in bone formation as well
as bone maturation and is the only known hormone to induce the proteins involved in active
intestinal calcium absorption [1–3]. Along with parathyroid hormone (PTH), it regulates calcium
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and phosphorous metabolism and enhances the absorption of calcium in the gut and reabsorption of
filtered calcium in the kidney [1–5].
When calcium concentrations decrease below normal physiological levels, calcium-sensing
proteins stimulate the secretion of PTH and the expression of PTH gene in order to restore calcium
homeostasis [1–5]. Consequently, the active 1α,25(OH)2D3 hormone stimulates intestinal calcium
absorption, or along with PTH, in the case of higher concentrations of the latter, increases mobilization
of calcium from the bone and renal calcium reabsorption [6–8]. Therefore, prolonged elevated PTH
concentrations will have a significant negative impact on bone health, consequently increasing the risk
of fractures and falls [6–8].
Inadequate vitamin D status, as well as inadequate dietary vitamin D and calcium intakes, are
considered independent factors linked to increased PTH concentrations [7,9]. Due to the fundamental
role of PTH in bone metabolism, the most common criteria used for determining the optimal
concentration for serum 25-hydroxyvitamin D (25(OH)D, the circulating metabolite) for bone health in
adults, include the suppression of PTH secretion [9–13]. Other parameters that may also be used for
determining optimal vitamin D status include higher bone mineral density, along with reduced rates
of bone loss and decreases in fractures and falls [9–13].
The relationship between PTH and vitamin D serum concentrations has been largely demonstrated
so far, however most studies were conducted in elderly and/or osteoporotic populations [9,10,12–14],
and moreover in high latitude countries (defined as latitude greater than 40◦ N or S), such as the
United States, Canada and most of Europe, including the United Kingdom. It is important to note that
in adults, increases in PTH may not be determined the same way and may not be as detrimental to
bone health as it has been shown to be in older populations. Moreover, vitamin D status can have
an independent protective effect on bone that would attenuate the negative effect of high PTH levels.
Thus, there is still a significant gap in our knowledge as to the importance of PTH suppression and a
considerable lack of data on healthy younger adults, particularly in low latitudes countries (lower
than 40◦ N or S), such as the African continent, Australia and most of Latin America, including Brazil,
where there is a higher and more constant level of sun exposure all year round [15,16].
Specific to the population groups living in low latitude locations, very few consistent studies
so far have evaluated vitamin D status in relationship with PTH. Thus, further data collection is
needed to better determine specific vitamin D recommendations for this particular papulation group
and geographical location. This study, therefore, aimed to determine the relationship between
serum 25(OH)D and PTH concentrations and to investigate whether there is a threshold for serum
25(OH)D concentrations where a minimum plateau in PTH is evident in Brazilian women living in
opposite latitudes.
2. Materials and Methods
This is a cross-sectional analysis of 25(OH)D and PTH concentrations, calcium and vitamin D
intake, conducted in 135 healthy adult (aged 20 to 59 years) Brazilian (born in Brazil and having at
least one parent born in Brazil) women, living in either England (51◦ N) or Brazil (16◦ S), recruited for
the D-SOL study (Interaction between Vitamin D Supplementation and Sunlight Exposure in Women
Living in Opposite Latitudes—clinicaltrials.gov as NCT03318029).
The study received a favorable ethical opinion from the University of Surrey (UEC/2016/009/FHMS)
and the Federal University of Goiás Ethics Committees and from the Brazilian National Ethics Committee
(CONEP) (CAAE/62149516.9.0000.5083, CEP-UFG/2013222; CONPEP/1972029; respectively).
2.1. Exclusion Criteria
The exclusion criteria included potential cofounders likely to affect vitamin D metabolism
(osteoporosis therapy, anti-estrogen treatment, antiepileptic drugs and cancer treatment), taking
supplements containing vitamin D (if the prospective participants agreed to stop vitamin D
supplementation to join the study, a wash-out period of 8 weeks prior to commencing the trial
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was accepted), being pregnant or planning a pregnancy during the study period, menopause status
(defined as the permanent cessation of menstruation) and living in the UK for less than 3 months at
the commencement of the study (for England participants only). All participants provided written
informed consent at the commencement of the study.
2.2. Data Collection
The dietary intake of vitamin D and calcium was determined by 4 consecutive days of estimated
diet diaries, including one weekend day. Participants were instructed by the research team on how to
correctly complete the diary and asked to give as much detail as possible of every meal, including
portion size.
Dietary intake data obtained from participants in the England cohort were analyzed using the
Nutritics® nutritional analysis software, version 4.0, Dublin, Ireland (UK Composition of Foods
Integrated Dataset (CoFID) including McCance and Widdowson 7th edition [17]) and those collected in
Brazil were analyzed via the Dietwin® software Version 13 (3090), Rio Grande do Sul, Brazil (Brazilian
Food Composition Table (TACO) [18] and the food composition database from the Brazilian Institute
of Geography and Statistics (IBGE), as well as the United States Department of Agriculture (USDA)
food composition database).
An overnight fasted (8 h) blood sample was collected by venipuncture by trained phlebotomists.
Processed serum and plasma samples were divided into aliquots and stored at −80 ◦C at the University
of Surrey, prior to analysis. Samples collected in Brazil followed the exact same procedures and were
temporarily stored at −80 ◦C at the Federal University of Goiás and sent to be stored at the University
of Surrey as well, prior to analysis.
2.3. Laboratory Analysis
Serum 25(OH)D concentrations were determined by the HPLC-MS/MS method on a Waters Acuity
UPLC (Triple Quadrupole) TQD® System using a Pentafluorophenyl (PFP) column following supported
liquid extraction (SLE). Laboratory intra- and inter-assay coefficients of variation (CV) were 5.6% and
7.8%, respectively. Calcium, albumin and PTH concentrations were measured using Abbott Architect
kits. Serum calcium was measured by using an endpoint spectrophotometric reaction based on the
o-cresolphthalein complexone methodology, and serum albumin was measured by using an endpoint
spectrophotometric reaction based on the bromocresol green solution dye binding methodology.
Serum calcium concentrations were adjusted for albumin concentrations. Plasma intact PTH was
measured by in vitro chemiluminescent microparticle immunoassay (CMIA). The manufacturer’s
quoted inter-assay CV for calcium was <3%, for albumin <3.8% and for PTH 4%.
The definition of optimal 25(OH)D status is still very debated within the scientific community
and continues to be controversial amongst different recommendations. For the purpose of this study,
vitamin D deficiency was defined as 25(OH)D concentrations below 25 nmol/L, as suggested by
the UK Scientific Advisory Committee on Nutrition [19]; insufficiency as concentrations between
25–49.9 nmol/L and adequacy between 50–74.9 nmol/L, as recommended by the US Institute of
Medicine [20]; and optimal levels as concentrations above 75 nmol/L, as proposed by the US Endocrine
Society [12].
2.4. Statistical Analysis
Statistical analysis of the data was undertaken using SPSS software for Windows (version 25.0, IBM
Corp, Armonk, NY, USA). Data were tested for normal distribution using the Kolmogorov–Smirnov
tests. Non-normally distributed variables were log transformed and reported on the original scale.
Non-parametric tests were used when log transforming did not normalize the data. Descriptive
statistics were determined for all variables. Continuous variables are presented as mean ± standard
deviation (SD). Baseline characteristics (age, dietary intakes and biomarkers) were compared between
countries, by independent t-tests or Mann–Whitney.
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For the whole sample and in each country separately, Pearson (or Spearman) correlation tests
were used to investigate the relationship between PTH concentrations and serum 25(OH)D, calcium
concentrations and vitamin D and calcium intakes.
One-way ANOVA with post-hoc Tukey tests were used to compared PTH concentration between
different vitamin D statuses. One-way ANOVA and regression model fit tests were conducted for both
original and normalized PTH data (log transforming) for all analysis and there were no differences in
the statistical outcome, therefore only analysis with original data is reported.
Regression modelling was used to model the relationship between serum 25(OH)D and PTH
concentrations for the whole sample and in each country separately. A linear model represents no
plateau in the analyzed data whereas cubic or quadratic models suggest a plateauing pattern.
A p value of <0.05 was considered significant. For comparisons between groups, effect size based
on eta squared was defined as 0.01 as a small effect, 0.06 as a medium effect and 0.14 as a large effect.
3. Results
A total of 336 adult Brazilian women were screened for the study, 149 in England and 187 in
Brazil, of which 132 were excluded based on the exclusion criteria, 53 decided not to participate after
the screening process and 15 did not attend their baseline visit. Reasons for exclusion at screening are
detailed in Figure 1. In the Brazil cohort one participant did not have valid laboratory results and was
therefore excluded from database (Figure 1).
Of the participants enrolled for the D-SOL study after the screening process, 135 participants were
included in this cross-sectional analysis (n = 56 in England and 79 in Brazil) (Figure 1). In the England
cohort five participants were post-menopausal. There were no differences between analyses including
or excluding the 5 post-menopausal women, and therefore, only analyses including these participants
are reported here.
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3.1. Participant Characteristics
Participants characteristics for age, weight, BMI, vitamin D and calcium intake and 25(OH)D,
PTH and calcium serum concentrations have been previously published in Mendes et al., 2019 [21].
Brazilian women living in England were older, heavier and had a greater waist circumference than
those living in Brazil (p < 0.01). There were no significant differences between Brazilian women living
in England and in Brazil for BMI classification distributions although, in line with the weight data, the
mean BMI was significantly greater for Brazilian women residing in England.
Overall (n = 135) mean habitual vitamin D dietary intake was 2.4 ± 1.9 µg/day and mean calcium
intake was 625.1 ± 310.7 mg/day. Mean vitamin D and calcium intakes were significantly higher for
women living in England compared to women living in Brazil (p = 0.012 and p = 0.001, respectively)
(Table 1).
In participants living in England, mean 25(OH)D concentration was significantly lower than for
participants in Brazil (p < 0.001) (Table 1). There were no significant differences between Brazilian
women living in England and Brazilian women living in Brazil for serum calcium concentrations
(p = 0.066), which were within the normal range for all participants (Table 1).
Table 1. Characteristics of adult Brazilian women by country of residence (n = 135) 1.
England (n = 51) Brazil (n = 79) p Value 2
Age (years) 35.55 ± 9.03 28.43 ± 7.14 <0.001 b
Vitamin D intake (µg/day) 2.96 ± 1.87 2.08 ± 1.86 0.012 b
Calcium intake (mg/day) 728.49 ± 318.75 547.47 ± 282.79 0.001
Serum 25(OH)D (nmol/L) 36.06 ± 14.97 75.00 ± 22.13 <0.001
Plasma PTH (pmol/L) 5.36 ± 1.99 4.49 ± 1.47 0.004 b
Serum Calcium (mmol/L) 3 2.30 ± 0.09 2.28 ± 0.07 0.066 b
1 Values are mean ± SD. 2 Statistical analysis: Independent t-test, unless otherwise stated: b Mann–Whitney.
3 Albumin corrected serum calcium concentrations.
3.2. Plasma PTH Concentrations
Mean PTH concentration in Brazilian women living in England was significantly higher than
within Brazilian women living in Brazil (5.36 ± 1.99 pmol/L and 4.49 ± 1.47 pmol/L, respectively
p = 0.004) (Table 1). PTH concentrations ranged from 2.41 to 13.76 pmol/L within those living in
England and from 2.18 to 8.51 pmol/L in participants living in Brazil.
PTH concentrations were negatively correlated with 25(OH)D concentrations (r=−0.285, p= 0.001)
and there was no significant correlation between PTH and calcium concentrations (r = −0.093, p = 0.285)
(data previously published) [20]. There were no statistically significant correlations between PTH
concentrations and vitamin D (r = 0.083, p = 0.372) and or calcium (r = 0.049, p = 0.596) intakes, even
when controlled for 25(OH)D concentrations (all p > 0.05).
3.3. Differences in Mean PTH Concentrations by Vitamin D Status
There was a statistically significant difference in mean PTH concentrations between the different
vitamin D status groups (F (3, 130) = 6.5, p <0.001; n = 135), with a large actual difference in mean
PTH concentrations (effect size = 0.14). Post-hoc comparisons showed that mean PTH concentrations
for deficient (6.60 ± 2.47 pmol/L) were significantly different from insufficient (4.96 ± 1.70 pmol/L;
p = 0.009), adequate (4.55 ± 1.39 pmol/L; p = 0.001) and optimal (4.42 ± 1.51 pmol/L; p <0.001) status
(Figure 2) [12,19,20].
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the best statistically significant fit (n = 135, R2 = 0.109, p = 0.002), with PTH reaching a minimum
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(Figure 3)).
Figure 3. Relationship between serum 25(OH)D and PTH concentrations (n = 134, R2 = 0.113, p = 0.001).
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When each latitude was assessed separately, a linear model was presented as the best fit with
statistical significance (n = 56, R2 = 0.076, p = 0.04) for Brazilian women living in England (Figure 4),
whereas for Brazilian women living in Brazil there was no statistical significance for any of the models
applied (n = 79, all p > 0.25).
Figure 4. Relationship between serum 25(OH)D and PTH concentrations for Brazilian women living in
England (n = 56, R2 = 0.076, p = 0.04).
3.5. Assessment of Higher 25(OH)D, PTH and Calcium Concentrations and Adverse Events
Only Brazilian women living in Brazil had serum 25(OH)D concentrations above 100 nmol/L (n= 3),
of which two women had concentrations above 130 nmol/L (134.9 and 148.6 nmol/L). Nine Brazilian
participants living in England and five living in Brazil had PTH concentrations above 6.9 pmol/L.
Serum calcium concentrations were within the reference range for all participants (<2.5 mmol/L). None
of the participants reported any adverse events throughout the duration of the study.
4. Discussion
Mean PTH concentration in Brazilian women residing in England was significantly higher than
within Brazilian women in Brazil, reflecting the significantly lower 25(OH)D concentrations in England
dwelling women observed in this study. The observed differences in 25(OH)D concentrations are most
likely due to expected differences in sunlight availability and exposure between the two countries.
Although there was a significant difference in mean age between the two groups, this would not be
likely to influence the state of vitamin D in these two populations since they were relatively young
and vitamin D production has been shown to start to decline later in life (over 50–60 years) [22,23].
PTH concentrations were negatively correlated with 25(OH)D concentrations and PTH clearly reached
a minimum plateau, representing the suppression of PTH secretion, at 25(OH)D concentrations of
70–80 nmol/L.
The definition of optimal status has been commonly derived from the level of 25(OH)D at which
PTH levels reach a minimum plateau, as a surrogate of optimal bone health, but this yields a wide
range of estimates. There is, however, a growing consensus that serum 25(OH)D concentrations of at
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least 75–80 nmol/L are required for optimal bone health [10,24]. The findings of the current analysis
are in accordance with this consensus, by suggesting that 25(OH)D concentrations above 70–80 nmol/L
would be optimal to reduce stimulation of the parathyroid gland in Brazilian women. These findings
are, therefore, of great relevance for discussions regarding the estimation of optimal cut-offs for vitamin
D levels in the Brazilian population as well as for other low latitude locations.
Several studies have associated increased PTH concentrations with adverse health outcomes,
particularly musculoskeletal issues [10,25–27], since secondary hyperparathyroidism is associated with
increased bone turnover rates and consequently increased bone loss [25,28]. Several studies have also
reported that the serum 25(OH)D concentrations at which PTH levels are suppressed vary substantially,
from either as low as 30 nmol/L to up to more than 100 nmol/L, while some other studies found no
relation between 25(OH)D and PTH, or found a linear relation without a plateau, meaning no clear
suppression of PTH secretion by 25(OH)D [10]. As has been demonstrated in other studies [10,25,27,28],
25(OH)D was shown to be negatively correlated with PTH in the present sample of adult Brazilian
women. In this sample, PTH concentrations for vitamin D deficient status were significantly higher
compared to the insufficient, sufficient and optimal status [12,19,20]. When analyzed separately a point
of inflection of plasma PTH could not be identified for either group, for Brazilian women living in
England a linear model was the only statistically significant model whereas within Brazilian women
living in Brazil there were no statistically significant models that fitted the data. This could be due to
the narrow range of serum 25(OH)D in Brazilian women living in England leading to a linear model
and due to the Brazil-dwelling group having higher 25(OH)D concentrations resulting in a less present
impact on PTH levels. A study with 389,004 Brazilian individuals of both genders aged 2 to 95 years,
throughout the four seasons, reported a sinusoidal interrelationship relationship between 25(OH)D
and PTH among individuals living in a subtropical area in Brazil, in which PTH levels showed an
inverted pattern of peaks in comparison to 25(OH)D levels [28].
There is a clear need for consistent data to establish realistic and meaningful recommendations
of vitamin D requirements, particularly for different ethnic/racial groups. Adding to the challenge
on the literature being still very controversial on recommended vitamin D status, currently most
recommendations have been based on studies conducted in high latitude countries with older
Caucasian populations.
The strengths of the present study include the inclusion of healthy adult Brazilian women, aged
20 to 59 years old, consisting of a representative sample, and the measurement of serum 25(OH)D
measurement via liquid chromatography–mass spectrometry. It is important to note that these findings
may not be generalizable to other ethnic groups with different characteristics, habits or culture.
When translating this into public health recommendations, the data presented here suggests that
the current recommendation for Brazilian adult women of 25(OH)D concentrations above 50 nmol/L [29]
might not be sufficient to reduce stimulation of the parathyroid gland in this population, which could
lead to serious detrimental effects to bone health, particularly when these women reach menopause.
This study shows that concentrations above 70–80 nmol/L would instead be required to better maintain
bone health in these women, as observed by the applied cubic model.
5. Conclusions
We concur with the current consensus as to the 25(OH)D optimal levels at which PTH secretion
is suppressed but demonstrate this in a previously unstudied population, specifically, healthy adult
Brazilian women. This data could also contribute to a better understanding of the relationship between
25(OH)D and PTH in populations living in a low latitude location. Moreover, with different generalized
guidelines proposing relatively differing definitions of vitamin D status, clinical recommendations on
vitamin D dietary intake and need for supplementation might be challenging. Thus, these findings
could be of great relevance for further discussions regarding the estimation of optimal cut-offs for
vitamin D levels specific for the Brazilian population. Further work to extend the findings in this
current research with larger and more diverse sample sizes, including men, is now warranted.
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